The New Hypertension Guidelines: Hits and Misses

Dr. Joseph L. Izzo, Jr., from the University at Buffalo/Erie County Medical Center, Buffalo, NY moderated the topic “The New Hypertension Guidelines: Hits and Misses” with Dr. Jan Basile from the Medical University of South Carolina/Ralph H. Johnson VA Medical Center, Charleston, SC, Dr. Marvin Moser from the Yale University School of Medicine, New Haven, CT, and Dr. Alan H. Gradman from the Temple University School of Medicine (Clinical Campus), Pittsburgh, PA participating. The discussion focused primarily on: What constitutes a good guideline; the usefulness of the new recommendations by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; the role of combination therapy in managing patients with resistant hypertension; the use of race as a decision point in selecting drugs for treating hypertension; specific recommendations for best practices when it comes to managing the hard-to-treat patient; and the existence and relevance of J-curves. (Med Roundtable Cardiovasc Ed. 2014;4(1):e54–e63) ©2014 FoxP2Media, LLC

[1]  Simon L Bacon,et al.  The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. , 2013, The Canadian journal of cardiology.

[2]  Willie Lawrence,et al.  An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention , 2013, Hypertension.

[3]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[4]  A. Schutte,et al.  Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. , 2014, Journal of hypertension.

[5]  Simon L Bacon,et al.  The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. , 2014, The Canadian journal of cardiology.

[6]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[7]  J. Izzo,et al.  Hypertension in diverse populations: a New York State Medicaid clinical guidance document. , 2011, Journal of the American Society of Hypertension : JASH.

[8]  G. Bakris,et al.  Combination Therapy in Hypertension , 2011, Journal of clinical hypertension.

[9]  M. Woodward,et al.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial , 2009, Diabetologia.

[10]  W. Elliott.  Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients , 2009 .

[11]  D. Goff,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[12]  F. McAlister,et al.  Re-examining the efficacy of β-blockers for the treatment of hypertension: a meta-analysis , 2006, Canadian Medical Association Journal.

[13]  M. Woodward,et al.  Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial , 2006, Journal of hypertension.

[14]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[15]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[16]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.